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Oligo- and polysaccharides (glycans) have fundamental roles in the development and function of
all living organisms. In vivo, they are most commonly found covalently bound to proteins or
lipids, forming glycoproteins and glycolipids. These molecular aggregates, known collectively as
‘glycoconjugates’, cover cell surfaces, often providing the first point of contact for host–pathogen
interactions. Carbohydrate-binding proteins on the pathogen surface target specific host glycans,
facilitating infection by both viruses and bacteria [1], perhaps the most well-known being the
interaction between viral hemagglutinin and glycans on human respiratory epithelium [2].
Inhibition of the binding of adhesin proteins to host glycans forms the basis of anti-adhesion
therapies [3]. Glycans are formed through the actions of various enzymes, which are responsible
for both their assembly (transferases) and their degradation (glycosidases). Any alteration in the
abundance or relative levels of such enzymes in an organism will be reflected in changes in the
pattern of protein and cell-surface glycosylation, often disrupting normal cell development and
leading to characteristic phenotypes, such as congenital diseases of glycosylation [4]. Moreover,
aberrant glycosylation is a signature of many diseases, from rheumatoid arthritis [5] and IgA
nephropathy [6] to a range of cancers [7–9]. Consequently, the development of treatments aimed
at targeting glycan-processing enzymes represents a viable and innovative therapeutic approach
[10,11]. In particular, the development of methods for characterizing the glycosylation state of
serum proteins for disease diagnosis and surveillance is an active area of research [12,13]. On
another front, polysaccharide chains present on the surface of many bacteria are the initialElisa Fadda1 and Robert J. Woods1,2
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The characterization of the 3D structure of oligosaccharides, their
conjugates and analogs is particularly challenging for traditional
experimental methods. Molecular simulation methods provide a basis for
interpreting sparse experimental data and for independently predicting
conformational and dynamic properties of glycans. Here, we summarize
and analyze the issues associated with modeling carbohydrates, with a
detailed discussion of four of the most recently developed carbohydrate
force fields, reviewed in terms of applicability to natural glycans,
carbohydrate–protein complexes and the emerging area of glycomimetic
drugs. In addition, we discuss prospectives and new applications of
carbohydrate modeling in drug discovery.Corresponding author:. Woods, R.J. (rwoods@ccrc.uga.edu), (rob.woods@nuigalway.ie)
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FIGURE 1
Influenza virus neuraminidase and transition state analog inhibitor. (a)
Structure of the de-esterified form of the neuraminidase inhibitor oseltamivir
in complex with the H274Y mutant of influenza virus N1 neuraminidase that
displays resistance to treatment with oseltamivir (PDBID 3CL0 [134]). (b)
Schematic representations of the natural substrate (neuraminic acid). (c)
Schematic representations of the inhibitor.
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Wantigens presented to the host immune system. Bacterial surface
polysaccharides, therefore, can be effectively employed in anti-
bacterial vaccines [14,15].
Clearly, glycans and carbohydrate-binding proteins present
numerous opportunities for therapeutic development [16].
Glycan chains can modulate the structure and function of the
protein to which they are attached, both by partially occluding
regions of the protein surface from direct interactions and by
damping the protein dynamics by virtue of their large mass and
inertial resistance [17]. Because of the intrinsic mobility of oligo-
saccharides, the use of X-ray crystallography (which has been very
successful in the study of proteins) is not straightforward. NMR
techniques are often applicable to glycans in solution, but the
scarcity of data often limits the ability of NMR spectroscopy to
determine uniquely the oligosaccharide 3D structure [18]. For
these reasons, the full extent of the relationship between glycan
3D properties and biological function is still being elucidated [19].
Computational methods and, in particular, molecular dynamics
(MD) simulations provide complementary tools to augment both
X-ray and NMR data and are particularly well suited to the char-
acterization of the structure and dynamics of glycans and glyco-
conjugates [20–22]. The two most important issues affecting the
quality of MD simulations are conformational sampling and force
field accuracy. In the early years of biomolecular simulations, MD
simulations were limited to small biological systems – such as
small proteins [23], short DNA helices [24] and mono- [25] or
disaccharides [26] – and ran for very short timeframes. From the
standpoint of today’s technical achievements, the early computa-
tional experiments might seem rather basic and obsolete; how-
ever, by emphasizing the dynamical nature of biomolecules and
the corresponding implication on biological function, the simula-
tions opened the way for the development of computer modeling
as a cornerstone of structural biology [27].
Advances in computer technology and software algorithms
enableus today to sample the conformational space of biomolecular
systems for on the order of hundreds of nanoseconds (ns). This
timeframe is typically adequate for most internal motions inglycans
[28,29]. It is also notable that exceptionally long timescales are not
necessary for all simulations to be useful. For example, MD simula-
tions can be very effectively employed in the refinement and
rescoring of ligand–protein complexes generated from automated
ligand docking [30–32]. In these scenarios, MD simulations are
performed principally to provide some level of ensemble averaging
to aid in generating robust affinity and specificity predictions.
This review is organized as follows: in the section ‘Protein–
carbohydrate interactions’, we summarize the characteristic struc-
tural features of carbohydrates and carbohydrate–protein interac-
tions. In the section ‘Carbohydrate force fields’, four recent
parameterizations of popular biomolecular force fields are dis-
cussed in detail, namely, those for CHARMM [33–35], GLY-
CAM/AMBER [36], GROMOS [37] and OPLS-AA [38]. In the
section ‘Discussion’, several issues pertinent to the extension of
carbohydrate modeling to other biomolecular systems and to
glycomimetic drugs are discussed (Fig. 1).
Protein–carbohydrate interactions
Because of the crucial role of carbohydrate–protein interactions in
human biology, there is considerable interest in employing com-putational simulations to help characterize these systems and aid
in the rational design of new therapeutics [10,39–41] and vaccines
[42–44].
Carbohydrate–protein interactions are often weak [45], facil-
itating the formation of transient states, which might aid in
targeting the protein to its destination [46]. For example, dissocia-
tion constants for most lectin–monosaccharide interactions are in
the mM range [47]. Binding affinity generally increases with
increasing oligosaccharide size [48], but not always [49], and often
does not yield greater than mM dissociation constants [50,51].
Although it has been technically possible to simulate the structure
of a carbohydrate–protein complex for more than a decade, the
accurate prediction of binding affinity remains a challenging task
[44,52], which is highly dependent on the ability of the force field
to reproduce both the solution and the bound properties of the
carbohydrate and the protein.
A considerable challenge comes from the fact that carbohy-
drate–protein interaction is intrinsically more dynamic than many
other protein–ligand adducts and that their affinity arises from
several relatively weak interactions. Indeed, carbohydrate-binding
specificity results from the subtle balance of electrostatic, hydro-
gen bonding (H-bonding) and hydrophobic interactions between
the protein, the solvent and the carbohydrate, which result in
significant changes in both enthalpy and entropy upon binding.
Charged residues (such as Arg, Lys, Asp and Glu), as well as ions,
are commonly found in the active sites of carbohydrate-binding
proteins [53,54]. As an example of carbohydrate binding in lectins,
we show in Fig. 2 the complex between concanavalin A and a
trimannoside (PDBID 1CVN [55]). The key interactions between
protein and carbohydrate in the binding site are highlighted,
indicating direct H-bonds between the trimannoside and twowww.drugdiscoverytoday.com 597
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FIGURE 2
Water-mediated carbohydrate – protein binding in Concanavalin A. (a) A complex of concanavalin A (ConA)with trimannoside (PDBID 1CVN [55]). (b) A close-up of
ConA binding site. Key residues for carbohydrate binding and recognition are highlighted: Asp 16 and Asp 208 in red, Arg 228 in blue, and Asn 14 in purple. The
trimannoside is colored according to its atom types. The oxygen of a key water molecule is also represented as a red van der Waals (vdW) sphere.
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cule is also directly H-bonded to the sugar and serves as a center for
H-bonding networks with one Arg and one Asn. Such direct
interactions are often cited as a major contribution to binding
enthalpy. Clearly, there is an absolute requirement for a high level
of compatibility between the force field treatments of carbohy-
drate and the protein electrostatics. For example, if the protein
force field employs partial charges derived by fitting to quantum
mechanical (QM)-derived molecular electrostatic potentials
(ESPs), it would seem reasonable that the ligand should also.
Notably, some computational approaches, such as some molecular
docking protocols [56], often assign non-ESP-derived charges to
the ligand to expedite the generalization of the method. Such
mixed electrostatic models must resort to empirical adjustment of
the interaction energy terms to compensate to some extent for the
imbalance. The need in general to employ protein-consistent
partial charges in the ligand and with the need for appropriate
torsion terms, are significant bottlenecks with regard to applying
biomolecular force fields to small molecule modeling. This is
certainly an issue in the specific case of extending carbohydrate
force fields to glycomimetic design [39].
Although many carbohydrates are neutral species, biologically
relevant glycans often contain charged monosaccharides or
charged derivatives, such as N-acetylneuraminic acid and sulfated
glycosaminoglycans, respectively. Recognition of such species
takes place through complementary electrostatic and H-bonding
interactions with protein residues. In such cases, the accurate
evaluation of electrostatic interactions is crucial for the correct
description of carbohydrate protein recognition.
Recognition and binding of carbohydrates to proteins does not
always involve charge–charge interactions, but most frequently it
takes place through the formation of complex H-bonding net-
works. H-bonding schemes involving two or three hydroxyl598 www.drugdiscoverytoday.comgroups are usually at the core of carbohydrate-binding specificity.
For instance, lectin specificity is often explained in terms of
orientation of the polar residues in the binding site that allow
the formation of H-bonds only with specific monosaccharides
[57]. The loss of a single specificity-defining H-bond – by chemical
alteration of the ligand, for example – will, generally, drastically
reduce affinity [58], and the use of deoxy sugars to map the
carbohydrate-binding site specificities of proteins was a powerful
technique [59] before the widespread availability of protein crys-
tallography. Although carbohydrate–protein H-bonds are readily
identifiable in crystal structures and clearly crucial for defining
specificity [60], however, they do not necessarily contribute sig-
nificantly to enhancing the affinity of these interactions [58]. This
is not as surprising as it might at first seem, when it is recalled that
the affinity arises from the difference in free energy between the
free and bound states. In the free states, both the ligand and the
protein are hydrated and, in fact, crystallography [61] and MD
simulations [62] have demonstrated that the protein frequently
will have discrete water molecules in the carbohydrate-binding
site, located in positions approximately equivalent to the sites in
which carbohydrate hydroxyl groups are to be found in the com-
plex. Thus, qualitatively, there is little gain in enthalpy to be
expected upon replacing these waters with the hydroxyl groups
of the ligand.
By contrast, there might be significant changes in entropy asso-
ciated with displacing bound waters from each interacting surface
[63,64]. Indeed, entropic contributions have been implicated as a
major factor in determining carbohydrate-binding affinity [65].
Computational simulations provide a unique tool to dissect
these interactions into their component energies [44,52,61],
which should greatly assist in the development of glycomimetics.
Carbohydrates are amphipathic molecules. They contain sig-
nificant hydrophobic patches, arising from aliphatic hydrogen,
Drug Discovery Today  Volume 15, Numbers 15/16 August 2010 REVIEWS
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aromatic residues in the active sites of many carbohydrate-binding
proteins plays a key part as in determining their affinity and to a
lesser extent specificity. The amino acid side chains of Trp, Tyr or,
less frequently, Phe residues are often seen stacked against the
bottom face of pyranose rings [53] and can contribute approxi-
mately 0.5–1 kcal/mol to the binding free energy [66]. The
heparin–AT3 complex is normally used as an example of carbohy-
drate recognition based on strong electrostatic interaction. None-
theless, it has been reported that as much as 60% of the total
affinity comes from non-ionic interactions, with 43% of the total
coming from interactions with only two Phe residues [67] (Fig. 3).
To account correctly for the dispersive component of these inter-
actions [68], the non-bonded van der Waals (vdW) interactions in
both carbohydrate and protein parameter sets need to be consis-
tent. It is noteworthy here that one of the advances likely to
further enhance the accuracy of carbohydrate simulations will
be the use of improved water models. Maximal benefit from the
use of improved water models, however, will probably also depend
on the development of carbohydrate force fields, tuned for use
with the particular water model. For example, in the case of the
GLYCAM force field, consistency with the TIP5P water model [69]
was achieved by introducing lone pairs into the oxygen atoms [70].
Carbohydrate force fields
MDsimulationsare based onthe deterministicpropagationof forces
acting on a molecular system [71,72]. Through MD simulations, it is
possible to observe, at the atomic level, the progression of molecular
motion. Given atomic positions and velocities, forces are calculated
on the fly, as derivatives of the potential energy (V (r1, . . ., rN)), at
specific time steps. The potential energy for a molecular system at a
time ti can be expressed in classical mechanics as a function of the
atomic positions using the familiar energy terms in Eqn (1):
Vðr1; . . . ; rNÞ ¼
X
i< j
Vbondsðri jÞ þ
X
i< j< k
Vanglesðui jkÞ
þ
X
i< j< k<h
Vdihedralð’i jkhÞ þ
X
i< j
VCoul:ðri jÞ þ
X
i< j
VLJðri jÞ
(1)[(Figure_3)TD$FIG]
FIGURE 3
Detail of a complex between antithrombin (AT3) and heparin (PDBID 1SR5
[135]). Heparin is colored according to its atom types, and two Phe keys for
heparin binding are highlighted in purple. The Arg and Lys residues in the
binding site are shown in light gray.where Vbonds, Vangles and Vdihedral refer to the potential energy
associated with bond-stretching, angle-bending, and proper
(and improper) dihedral angle rotations, respectively. VCoul. and
VLJ refer to the pairwise electrostatic interaction and to the Len-
nard-Jones (LJ) repulsion–dispersion potential terms, respectively.
Classical force fields are defined by the functional form of these
components and by the set of parameters that each term requires.
Force field development is a challenging and necessarily meti-
culous task. It requires the determination of empirical parameters
that when introduced in Eqn (1) lead to the correct potential
energy landscape of the molecular system. Although early force
field parameterizations employed principally experimental data,
today their development is more often achieved with a mixture of
high-resolution experimental data and QM data. Because of the
coupling between many of the force field terms (e.g. torsions and
electrostatics), approaches to parameterization inevitably require
multiple sets of calculations, for development and testing; the
more well-defined the force field refinement protocol, the more
probably the resultant parameters will be broadly applicable [73].
The definition of valence interactions, modeled in most biomo-
lecular force fields by bond-stretching, angle-bending and dihedral
terms, requires the determination of force constants and equili-
brium values for the distances and angles,
Vbondsðri jÞ ¼ 12kbi jðri j  r0i jÞ
2
(2)
Vanglesðui jkÞ ¼ 12kui jkðui jk  u0i jkÞ
2
(3)
Vdihedralð’i jklÞ ¼ 12k’ð1þ cosðn’þ gÞÞ (4)
In Eqn (2), kbi j and r
0
i j indicate the bond-stretching constant and the
equilibrium distance, respectively. In Eqn (3), kui jk and u
0
i jk indicate
the angle-bending constant and the equilibrium angle, respectively.
It shouldbenoted that the equilibrium valuesare notnecessarily the
values observed experimentally but are adjusted to achieve the best
overall reproduction of the experimental (or theoretical) values for
discrete molecules. Finally, in Eqn (4), kw, n, and g are the torsion
constant, multiplicity and phase angle, respectively. It should be
emphasized that torsion terms are corrections to the computed
rotational energy profiles to ensure agreement with observed values
(most often from QM calculations) and in a well-tuned force field
represent principally contributionsonly from non-classical through
H-bond interactions, such as hyperconjugation, electron delocali-
zation and polarization. Improper potential energy terms may also
be included in the force field to enforce structural requirements,
such as chirality, or planarity of atoms in p-conjugated functional
groups (such as peptide planes).
Non-bonded interactions are determined by the ESP and the
repulsion–dispersion (i.e. vdW or LJ) potential. In classical force
fields, charge polarization is in a general sense implicitly incorpo-
rated into torsions and vdW terms, which cannot be expected to
reproduce effects arising from discrete atomic interactions. The
explicit inclusion of charge polarizability is increasingly being
considered [74]; however, it remains a challenge for parameteriza-
tion [75] and leads to significant increases in computer demands.
Eqn (5) shows the Coulomb ESP between point charges qi and qj
located at a distance Rij in a medium with dielectric constant er,
VCoulombðri jÞ ¼ 1
4pe0
qiq j
erRi j
(5)www.drugdiscoverytoday.com 599
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performed with explicit solvent, the dielectric constant is gener-
ally set to unity; however, it has been argued that a value of
between 3–4 Debye might be appropriate in environments where
charge polarization would otherwise be expected to lead to further
electrostatic shielding [76].
The LJ potential for non-bonded interactions is shown below in
Eqn (6),
VLJðRi jÞ ¼ 4ei j
si j
Ri j
 12
 si j
Ri j
 6" #
(6)
where eij and sij are LJ repulsion–dispersion parameters, defined for
each atom pair. The functional form of this term varies, but in all
cases, it includes a steeply repulsive component (/ R12). This
dominates at short inter-atomic distances over the weakly attrac-
tive term (/ R6), but at intermediate distances, they combine to
approximate the weak attractions that arise from instantaneous
dipole-induced dipole attractions. Both terms asymptotically
approach zero at infinite separation.
The parameter development protocol is fundamentally a matter
of philosophical conviction or developmental legacy require-
ments; thus, it is specific to each force field. Small differences in
the parameter sets can lead to significant differences in the energy
landscape, such as location and depth of minima [77,78]. Mixing
parameters from different force fields, therefore, can result in a loss
of internal consistency and, consequently, in erroneous simula-
tions. This is profoundly important for flexible molecules such as
oligosaccharides, the state populations of which are particularly
sensitive.
The development of a robust carbohydrate force field is a
particularly challenging task because of the need to consider
the influence of the inherent flexibility of glycans on the approach
to parameter development and validation. In addition, unlike
proteins and oligonucleotides (which are built by linear assembly
of residues), glycans are often branched structures. As shown in
Fig. 4, the majority of carbon centers in a monosaccharide are
chiral and bear a hydroxyl group. Each hydroxyl group can form a
glycosidic link to another carbohydrate unit. Although only one
dipeptide can be generated from the same two amino acids, 20
chemically distinct disaccharides can be formed from the same
two hexopyranose monosaccharides. In analogy with proteins,
however, glycan conformation is generally defined by the torsion
angles between the residues (e.g. w and c) (Fig. 4). Additional
degrees of freedom are associated with hydroxyl group rotations
and rotation around the C5–C6 v-angle, when present (Fig. 4).
[(Figure_4)TD$FIG]FIGURE 4
Illustration of the w, c and v dihedral angles for a representative 1–4 linked
disaccharide (maltose).
600 www.drugdiscoverytoday.comThe C–O–C–O atomic sequence (C5–O5–C1–O1 in pyranoses) is
omnipresent in carbohydrates (Fig. 4), and its associated stereo-
electronic effects radically differentiate the conformational prop-
erties of glycosides from those of structures based on cyclohexane
or those in which the linking oxygen is replaced by a methylene
group (C-glycosides) [79]. Ultimately, the degree to which a force
field is able to correctly reproduce the stability and conformation
of the carbohydrate ring and the interactions between the rings
depend on a delicate balance between inter- and intramolecular
forces [28]. The anomeric effect [80] identifies the preference of the
electronegative substituent at the anomeric carbon (C1 in aldoses)
for an axial configuration (a-anomer), rather than for the equator-
ial orientation (b-anomer). This preference has its basis in the
electronic structure of the O5–C1–O1 atomic sequence. The widely
accepted justification for the anomeric effect is that it originates
from hyperconjugation between molecular orbitals (np) associated
with the ring oxygen atom (O5) and the adjacent C1–O1 bond (s*),
although there are other interpretations [81]. For pyranoses, sta-
bilizing hyperconjugation is maximized in the a-anomer [82–84].
The exo-anomeric effect arises again from hyperconjugation
within the O5–C1–O1 sequence, but this time it is between O1
(np) and the O5–C1 bond (s*) and manifests itself as a rotameric
preference about the exocyclic C1–O1 bond (known as the w-
angle). Unexpected rotameric preferences are also seen for the
exocyclic hydroxymethyl group (C5–C6 bond or v-angle in hex-
opyranoses). In contrast to expectations based solely on steric
effects, this single bond displays a strong preference for rotamers
in which O6 and O5 are in a gauche orientation (Fig. 5). In contrast
to the anomeric effect, the gauche effect is principally caused by
solvation and electrostatic interactions [28], rather than steric or
stereoelectronic effects. Rotamer preferences for this bond can
profoundly impact the conformational properties of oligosacchar-
ides containing 1–6 linkages, which are common in mammalian
and bacterial cell-surface glycans [85–87]. The correct evaluation
of the rotamer preferences for the v-angle is a notoriously challen-
ging task for carbohydrate force fields [88]. This is due to the need
for delicately balanced inter- and intramolecular interactions and
to the relatively long lifetimes of some states [28,29].
The choice of treatment of 1–4 non-bonded interactions in a
carbohydrate force field is crucial for the correct reproduction of
the rotational preference around the v-angle [28]. In several
biomolecular force fields, such as OPLS-AA [89] and AMBER
[90], 1–4 non-bonded interactions are dampened, relative to
longer range interactions, by the introduction of scaling factors.
In carbohydrates 1–4 scaling hinders the correct parameterization
of the exocyclic v torsion (Fig. 4) in hexopyranoses. In fact, the
weakening of 1–4 interactions (O6–O5), relative to 1–5 (O6–O4),
prevents the accurate fitting of the rotational properties for this
linkage [78,91]. Conversely, choosing not to use 1–4 scaling factors
may cause a conflict with the treatment of non-bonded interac-
tions in protein force fields. Thus, it might be necessary to employ
separate treatments of 1–4 scaling in each class of molecule,
particularly in the simulation of glycoproteins. It is worth noting,
though, that when glycans bind to proteins, large internal rota-
tions are generally reduced; thus, in the case of carbohydrate–
protein complexes, the potential impact of choice of 1–4 scaling
often becomes irrelevant and the default scaling appropriate for
the protein may be employed.
Drug Discovery Today  Volume 15, Numbers 15/16 August 2010 REVIEWS
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FIGURE 5
Newman projections of the gauche–gauche (gg), gauche–trans (gt) and trans–gauche (tg) rotameric conformers of the v dihedral angle. The gg, gt and tg
conformers are defined relative to the O5–C5–C6–O6 and C4–C5–C6–O6 torsions. R
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generate force field terms specific to carbohydrates [91]. Each
of these protocols results in a unique parameter set, with
characteristic strengths and weaknesses not only in terms of[(Figure_6)TD$FIG]
FIGURE 6
Approximate estimate of the usage of carbohydrate force fields developed after 19
and SPASIBA [139]. Each slice is proportional to the number of citations of the semin
(http://scientific.thomsonreuters.com/products/wos/).performance but also in terms of ease of implementation,
transferability or generality for extension to glycans outside
of the original parameterization scheme or to glycomimetics,
as well as compatibility with other biomolecules and solvent90; namely, GLYCAM, AMBER, CHARMM, OPLS-AA, GROMOS, MM4 [136–138]
al force field paper in the past five years, according to the ISI ‘Web of Science’
www.drugdiscoverytoday.com 601
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TABLE 1
Rotamer populations (%) for the v-angle (gg:gt:tg) in methyl a-D- and b-D-gluco- and galactopyranosidesa
a-D-Glcp-OMe b-D-Glcp-OMe a-D-Galp-OMe b-D-Galp-OMe
Simulation
CHARMM [34] 47:45:6 34:59:7 4:46:50 6:49:45
GLYCAM06 [100] 62:36:2 – 8:75:18 –
GROMOS45A4 [37] 54:46:0 55:45:0 31:38:31 34:41:25
OPLS-AA-SEI [38] 67:29:4 – 9:53:38 –
Experiment
[111] 57:38:5 – 16:75:9 –
[109] 53:47:0 – 14:47:39 –
[110] – – 21:61:18 –
[112] 40:53:7 31:61:8 3:74:23 3:72:25
a See also Fig. 5.
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usage of several popular carbohydrate force fields developed
since 1990. Each slice is proportional to the number of citations
that the original force field paper received during the past five
years.3
Several reviews of earlier developments of carbohydrate force
fields are available in the literature [77,91–95]. In the next sections,
we discuss the most recent developments of widely used carbohy-
drate force fields (i.e. CHARMM, GLYCAM06, GROMOS-45A4 and
OPLS-AA-SEI). A summary of the main characteristics of each of
these force fields, with particular emphasis on the approaches to
parameter derivation and validation, is presented in the following
sections.
CHARMM
The CHARMM force field for carbohydrates [33–35] is the most
recent addition to the CHARMM all-atom biomolecular force field
[96,97]. The current parameterization enables the simulation of
monosaccharides (i.e., common hexoses in pyranose or furanose
forms) and their oligosaccharides. Consistent with the CHARMM
all-atom force field development protocol [93], the carbohydrate
parameterization is based on a hierarchical approach. The first
parameter set was developed for glucopyranose monosaccharide
[34]. Initial parameters were generated for six model compounds
corresponding to fragments of a pyranose ring: methanol, ethanol,
isopropanol, ethylene glycol, cyclohexane and tetrahydropyran.
This preliminary set was applied directly to monosaccharides and
then refined to reproduce QM data and experimental properties
[34]. The QM data included vibrational frequencies4, conforma-
tional energies5, solute–water interaction energies6 and dipole
moments. The reference experimental data set included thermo-
dynamic quantities [i.e. heat of vaporization (DHvap), molecular
volume (Vm) and free energies of solvation], IR vibrational fre-
quencies, X-ray crystallographic intramolecular and unit-cell geo-
metries, densities of concentrated water–glucose solutions, and
thermodynamics and dynamics of exocyclic group rotation. Dihe-
dral terms were obtained directly on monosaccharides by fitting
over 1800 QM conformational energies.7 The final refinement step3Web of Science (http://scientific.thomsonreuters.com/products/wos/).
4 QM vibrational frequencies calculated at the MP2/6-31G(d) level of theory.
5 QM conformational energies for the model compounds were calculated at
the MP2/cc-pVTZ level of theory.
602 www.drugdiscoverytoday.comconsisted of MD simulations of monosaccharides in different
media, with the aim of obtaining parameters suitable for the
simulations in condensed phase.
Non-bonded interaction parameters have been derived to repro-
duce carbohydrate–water interactions by fitting to scaled QM
solute–water interaction energies and distances. Further refine-
ment was done against experimental heats of vaporization and
molecular volumes of neat liquids. Non-bonded interactions were
evaluated in aqueous solution at different concentrations of glu-
copyranose in TIP3P water [126] to assess the transferability to
monosaccharides of the non-bonded parameters developed for
small model compounds. The results for the solution densities
showed less than 0.1% deviation relative to experiment, and based
on these results, the non-bonded interaction parameters devel-
oped for the model compounds were transferred directly to the
monosaccharides without further refinement. Different atom
types were introduced for a- and b-anomers.
Validation tests confirm the ability of the force field to repro-
duce structure, dynamics and thermodynamic properties of glu-
cose as a crystal and in aqueous solution. In conformity with the
CHARMM biomolecular force field, no scaling factors were used to
reduce 1–4 non-bonded interactions and the rotational prefer-
ences of the exocyclic group were analyzed for a- and b-D-gluco-
and galactopyranose [34].
The rotamer population analysis (Table 1) shows considerable
variations in the experimentally derived populations. This reflects
the limitations associated with the approximations employed in
each case to convert the experimental NMR observables (typically
J-values) to populations. Variations also arise from differences in
the precision of the experimental measurements. To avoid some of
these issues, it has been proposed that derivation of the experi-
mental observable from the MD data is preferable to derivation of
rotamer populations from NMR data [98]. Comparing experimen-
tal and theoretical J-couplings lacks the ease of physical interpre-
tation of rotamer populations, and there are approximations
associated with the computation of theoretical J-values [29];
nevertheless, such comparisons provide a more quantitative
assessment of the level of agreement between experiment and6 QM solute–water interaction energies were calculated at the HF/6-31G(d)
level of theory.
7 QM conformational scans for the monosaccharides were performed at the
MP2/6-31G(d) level of theory.
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lations with the CHARMM force field correctly reproduced the
general rotamer preferences associated with the gauche effects in
gluco- and galactosides.
The extension of the CHARMM force field to oligosaccharides
required the addition of torsion parameters appropriate for gly-
cosidic linkages [35]. All glycosidic torsional terms have been
derived by fitting QM 2D-scans8 for tetrahydrofuran disaccharides
and for tetrahydrofuran monosaccharide linked to cyclohexane.
All glycosidic linkages have been scanned separately. The final
parameter set was validated via MD simulations of disaccharides in
aqueous and crystal phases and compared to X-ray geometries,
experimental solution densities and NMR J-coupling data. Bond
and angle parameters and point charges were initially transferred
directly from the set developed for the monosaccharides, then
adjusted to ensure good agreement with experimental geometries
and conformational energies. The final optimized parameter set
reproduces both conformations and relative energies of the a- and
b-anomers relative to QM data.9
To extend the force field to five-membered sugar rings (fura-
noses), the bonded and non-bonded parameters were transferred
directly from the set developed for pyranoses [34] and cyclic ethers
[99]. Crystal phase simulation results showed that only slight
modifications to bond and angle equilibrium values were neces-
sary to accurately reproduce the crystal structure geometries [33].
New torsion parameters were derived to reproduce the unique ring
puckering potential energy landscape associated with five-mem-
bered rings. The protocol involved the fitting to QM potential
energy surfaces (see footnote 9) of arabinofuranose and ribofur-
anose by means of a Monte Carlo simulated annealing method
[100]. The optimized parameters were able to reproduce the QM
torsional conformation energies within 1 kcal/mol. Ring pucker
parameters and probability distributions were determined through
MD simulation in water. The simulation results satisfactorily
reproduced the experimental pseudorotation angles and ampli-
tudes, as well as the qualitative trend of exocyclic rotamer popula-
tion. The final optimized parameter set was validated against QM
HF/6-31G(d) sugar–water interaction energies and distances, crys-
tal lattice parameters, aqueous solution experimental densities
and NMR conformational properties.
GLYCAM06
GLYCAM06 represents a complete, self-contained and transferable
set of parameters for the simulation of carbohydrates and glyco-
conjugates [36]. GLYCAM06 parameters can be used for the simula-
tion of carbohydrates of all ring sizes and conformations for both
monosaccharides and oligosaccharides. Moreover, it includes para-
meters for many non-standard carbohydrate derivatives commonly
found in complex biomolecular systems, such as N-acetylneurami-
nic acid (sialic acid), N-acetylglucosamine, N-acetylgalactosamine,
N-acetylmannosamine, and glucuronic and galacturonic acids. As
in the previous versions of GLYCAM [28,101], the parameterization
protocol varies subtly from that employed for proteins within the8 QM 2D-scans calculated at the MP2/6-31G(d) level with conformational
single point energies at the MP2/6-31G(d) level of theory.
9 QM unrestrained potential energy surfaces obtained at the MP2/cc-pVTZ//
MP2/6-31G(d) level of theory.AMBER all-atom force field, most notably in the fitting of partial
charges, but maintains overall consistency [90,102]. Such consis-
tency is particularly important for the simulation of glycoconju-
gates. GLYCAM06 is the only current carbohydrate force field that
contains parameters for N-glycosidic linkages [36]. These para-
meters are suitable for combination with the param99sb version
of the AMBER all-atom protein force field [103], enabling the
simulation of glycoproteins and glycopeptides. GLYCAM06 has
been applied in combination with the AMBER protein force field
to study a diverse range of interactions with proteins, including
those of relevance to infection [104], cell development [105] and
biomass conversion [106]. Because GLYCAM06 is self-contained, it
can be employed in simulation packages other than AMBER; how-
ever, great caution should be taken before attempting to mix the
GLYCAM parameters for carbohydrates with non-AMBER para-
meter sets. Although tools exist to convert the GLYCAM force field
files to formats appropriate for use with other simulation packages
[107], it is important to carefully check the results of any file
conversions to ensure the reproduction of relevant benchmarks.
A distinctive feature of the GLYCAM06 force field, in contrast to
earlier versions of GLYCAM [28,101] and in contrast to the other
force fields reviewed here, is the use of the same carbon atom type
(CG) for the anomeric centers in both a- and b-glycosides. This
feature was achieved by fitting torsion terms to rotational data
from small achiral molecular fragments, rather than to tetrahy-
dropyran-based models of intact a- and b-pyranosides; thus,
neither anomer-specific torsion terms nor torsion phase correction
terms were employed. This feature facilitates the simulation of
ring-flipping, which is known to exist in certain monosaccharides,
leading to equilibrium between conformers with axial and equa-
torial substituents at the anomeric center. This equilibrium is akin
to an interconversion between a- and b-anomers, which is not
straightforward to simulate with force fields that employ unique
torsion terms for a- and b-anomers. This may also be expected to
be a significant issue when simulating oligosaccharides bound to
carbohydrate-degrading enzymes, in which non-standard ring
conformations are a hallmark of the transition state [108]. In point
of fact, if the transition state is a half chair, where the anomeric
center is neither axial (a-anomer in most pyranoses) nor equatorial
(b-anomer in most pyranoses), it is not immediately clear which
anomeric parameter set should be employed. For optimal repro-
duction of molecular ESPs, GLYCAM06 generally employs ensem-
ble-averaged partial charge sets that are specific for each anomer;
however, charge averaging can be employed to study variations in
conformational energies that relate to ring interconversions [36].
In contrast to many biomolecular force fields, including carbo-
hydrate force fields, the parameterization does not employ any
generic torsion terms (e.g. of the type X–C–C–X). All torsion terms
were derived in a hierarchical manner using fitting valence para-
meters to a series of more than 100 model compounds encom-
passing several molecular classes. These included hydrocarbons,
alcohols, ethers, amides, esters, carboxylates and mixed functional
groups, such as ether alcohols, ether amides, alcohol amides and
ether carboxylates. To ensure consistency, QM data were
employed to compute all torsion terms10, as well as for generating
stretching and bending force constants.11 As in the case of torsion
terms, the bond and angle force constants are fit to the difference
between the classical (MM) and the QM data, although in practicewww.drugdiscoverytoday.com 603
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the force constants are usually very similar to those derived by
directly fitting to the QM data. Where NMR data are useful for
evaluating the performance of parameters associated with bond
rotations, crystallographic data provide insight into the precision
of the valence bond lengths and angles. IR spectroscopic data can
address the suitability of the stretching and bending force con-
stants. When comparing to IR data, it is important to take into
account effects arising from the crystal lattice, which are not
reflected in an analysis of a single gas-phase geometry [58]. GLY-
CAM06 performs well in such comparisons, with the singular
exception of the vibration frequencies of the hydroxyl hydro-
gen–oxygen bond. The QM data employed to fit a force constant
to such a labile bond tend to overestimate its strength signifi-
cantly. The length, however, is unaffected and well reproduced,
relative to neutron-diffraction data.
In assessing the fits to the QM data for torsion terms, errors in
the relative energies of the minima and in the overall rotational
barriers were determined for the entire set of torsions by compar-
ing the QM to the GLYCAM06 rotational curves. For most classes
of model compounds, errors were less than 10% of the barrier
height. Given that many glycan are highly flexible, it is important
to characterize the fits to internal rotational curves. Carboxylates
and ether carboxylates (as in N-acetylneuraminic acid) have sig-
nificantly smaller rotational barrier heights; therefore, the relative
errors seem to be larger (i.e. 38% and 29%, respectively). Tests
performed on the axial and equatorial conformers of tetrahydro-2-
methoxy-2H-pyran show that the use of common torsion para-
meters for a- and b-anomers in GLYCAM06 enable it to reproduce
the QM rotational curves with quantitative accuracy [36]. This was
a concern because previous versions of GLYCAM benefited from
the simplicity and inherent precision of a single torsion term per
rotatable bond, whereas in GLYCAM06 the rotational energy
resulted from the sum of all contributing torsion terms. The
advantage of this approach is that it makes the extension of the
parameters to non-carbohydrates (such as lipids [109] or glycoli-
pids [110]) or chemical analogs (such as glycomimetics) straight-
forward.
Results, shown in Table 1, for the ability of GLYCAM06 to
reproduce the gauche effect, associated with 1–6 linkages, indicate
that the force field correctly reproduces the preference for the gg
conformer in D-glucopyranose and for the gt conformer in D-
galactopyranose. The conformer population analysis is also in
good agreement with the majority of the experimental data
[36,111–114]. The importance and challenges of such comparisons
were discussed in the preceding section.
To ensure consistency with the all-atom force field, non-bonded
vdW parameters were taken directly from the PARM94 parameter
set of AMBER [90] and atomic partial charges were derived from
fitting to molecular ESPs.12 Consistent with the AMBER partial
charge philosophy, the atomic charges are not generalized but are
unique to each atom in each residue. To capture, in part, the effect
of exocyclic group rotations (hydroxyl and hydroxymethyl, and so10 QM rotational curves were built by increments of 308 from 08 to 3608 at the
B3LYP/6-311++G(2d,2p) level of theory.
11 QM distortion curve calculated at the B3LYP/6-311++G(2d,2p) level of
theory.
604 www.drugdiscoverytoday.comon) the charges in GLYCAM were computed from the average of
the ESP-fit partial charges [115] determined for 100–200 confor-
mations of each monosaccharide. A feature that is unique to
GLYCAM is the use of solvated MD simulations to generate the
ensemble of conformations employed in the charge averaging.
Because of its iterative nature, this process is initiated with a single
ESP-fit charge set and can be repeated until convergence in the
charge values is achieved [116]. Such an approach leads to statis-
tically robust partial charges, enabling an assessment of the extent
to which each atomic center is electrostatically unique. On the
basis of this ensemble averaging, it was concluded that aliphatic
hydrogen atoms typically carried little if any significant charge.
Similar conclusions have also been reached from earlier studies
[116,117] and arise from the lack of a notable dipole moment for
most C-H bonds. Moreover, fitting partial charges in molecules
with many aliphatic hydrogen atoms leads to a degeneracy in the
fit, which is reflected in the high sensitivity of the partial charges
to ESP sampling protocols [118]. When eliminated from the fit-
ting, robust partial charges emerge. For these reasons, in GLY-
CAM06 restraints were applied to ensure that the charge on
aliphatic hydrogen atoms was zero (RESP). Because the C–H bond
dipole is generally negligible, forcing the neutrality of aliphatic
hydrogen atoms has no significant effect on the molecular dipole
moments. For each monosaccharide, an MD trajectory of typically
50–100 ns was run. The final RESP charges were obtained by
averaging the charges determined for the 100–200 snapshots
selected from each MD simulation with an optimal RESP weight-
ing derived from the simulation of carbohydrate crystal lattices
[119]. Different sets of conformationally averaged partial charges
were determined for a- and b-anomers. In all GLYCAM versions,
unique partial charge sets are computed for each residue, and the
charges are not transferable from monosaccharide to monosac-
charide or atom to atom. Although this leads to the more accurate
reproduction of ESPs for flexible molecules, it introduces an extra
level of complexity over other parameterization approaches based
on transferable charges (Table 3). The ensemble-averaged charge
sets were able to reproduce the geometries of crystal lattices of
monosaccharides, as well as IR spectral frequencies and the solu-
tion conformational properties of carbohydrates [36]. Although
the use of unique charge sets for each anomer results in optimal
representations of the external electrostatic properties, it may
negatively impact the reproduction of internal energies – as, for
example, the gas-phase relative energies of a- and b-anomers.
Quantitative reproduction of internal energies can, however, be
achieved when both anomeric charge sets are averaged, although
with some reduction in the accuracy of external electrostatics [36].
GROMOS 45A4
The 45A4 version of the GROMOS force field [37] contains the
latest carbohydrate parameter set developed consistently with the
GROMOS96 parameter set [120,121] for biomolecules. The 45A4
version includes parameters for mono- and oligosaccharides based
on pyranosides. It was developed as a refinement of the previous
45A3 parameter set [122,123] with the aim to correct for under-
estimation of the anomeric effect and for the incorrect dihedral12Molecular electrostatic potential determined at the HF/cc-pVTZ/HF/6-31G*
level of theory.
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lead to ring deformation [37]. The refinement consists of a re-
parameterization of atomic point charges and torsional terms.
Non-torsional covalent interactions and vdW terms have been
transferred directly from the previous version. As in GLYCAM06,
the torsion parameters were derived exclusively from fitting to QM
data. Atomic point charges were developed by a restrained fit of the
ESP [115] of cellotriose [i.e. b(1 ! 4)-linked D-glucopyranose tri-
saccharide].13 By employing a trisaccharide for charge develop-
ment, the charges on the central residue should be directly
transferable to larger polysaccharides containing the same residue
in the same sequence. The extent to which such a model is
transferable without loss of accuracy to other oligosaccharide
sequences remains to be determined. Restraints in the charge
fitting protocol included neutrality of the aliphatic hydrogen
atoms, with the molecular dipole moment restrained to the QM
value, and neutrality of the carbon–hydroxyl building blocks (e.g.
CH–OH and CH2–OH). Charges of topologically similar atoms
within the central unit of cellotriose were averaged (Table 3).
Charges for terminal C1–OH and C1–OMe groups were obtained
through a RESP fit on b-D-glucopyranose, where all charges on
other atoms constrained to the value determined for the central
unit of cellotriose. After GROMOS96 convention, 1–4 non-bonded
interactions are not scaled; however, first and second covalent
neighbors are excluded from the vdW pair-list [37].
Dihedral parameters were determined by fit of the MM to the
QM rotational energy profiles14 calculated for methyl a-D-gluco-
pyranoside and for methyl a-D-galactopyranoside. Specific para-
meters were assigned to w, c and v dihedral angles. a- and b-
anomers have been assigned different parameter sets.
Unlike the other force fields analyzed here, which are consistent
with the TIP3P water model, GROMOS 45A4 was developed for use
with the SPC water model. The force field was validated through a
series of 5 ns and 20 ns MD simulations of monosaccharides,
a- and b-D-gluco- and galactopyranose, and the disaccharides
trehalose, maltose and cellobiose in SPC water [124]. Analysis of
the ring conformational energies showed that the 4C1 chair is
predicted to be the most stable among the other four conforma-
tions studied (i.e. 1C4, B
1,4, B2,5 and B3,O). However, the boat B3,O
conformation was incorrectly placed at lower energy than the 1C4.
The conformational space of the v torsion for a- and b-D-gluco-
pyranose was sampled by performing a 20 ns MD simulation in
SPC water. Population analysis (Table 1) shows that the force field
correctly predicts the rotameric preference with a 46:0:54 ratio for
the gt:tg:gg rotamers (Fig. 5). Furthermore, interconversion
between gt and gg was observed in the ns timescale, in good
agreement with experiment [37]. Conformational maps calculated
for w and c torsions for the disaccharides were also in good
agreement with experimental data [37].
OPLS-AA-SEI
The OPLS-AA Scaling of Electrostatic Interactions (SEI) parameter
set [38] is a refinement of the carbohydrate parameter set included
in the OPLS-AA biomolecular force field [89]. New parameters were13 Geometry optimization and electrostatic potential calculated at the HF/6-
31G* level of theory.
14 Rotational profiles calculated at the HF/6-31G* level of theory.developed to improve the prediction of conformational energies
associated with the w and c angles of the exocyclic hydroxymethyl
rotameric distribution in solution [38]. The large discrepancies
observed in reproducing gas-phase relative energies were attribu-
ted not to the parameterization protocol of OPLS-AA but, mainly,
to an imbalance of 1–5 and 1–6 non-bonded interactions caused by
the scaling of 1–4 interactions. Rather than remove such scaling as
in the other three force fields, the new OPLS-AA carbohydrate force
field, namely OPLS-AA-SEI, included additional scale factors for 1–
5 and 1–6 non-bonded interactions. This scaling scheme corrected
for the shortcomings of the old parameter set for carbohydrates,
while maintaining compatibility with the functional form of the
biomolecular OPLS force field. 1–5 interactions in 1,2 ethandiol
and hexopyranoses were scaled by a factor of 1.25 and 1.26,
respectively. For hexopyranoses, 1–6 interactions involving the
hydroxymethyl group and the proximal hydroxyl groups were
scaled by a factor of 1.22. Such adjustments forced the re-para-
meterization of the associated dihedral terms.15 All non-torsional
valence and non-bonded parameters were imported directly from
the parent force field OPLS-AA [125]. Point charges in OPLS-AA
were derived for standard alcohols and acetals to reproduce prop-
erties of neat liquids and thermodynamic properties, such as heats
of vaporization [89,125], and transferred to carbohydrates. Valida-
tion of the final parameter set OPLS-AA-SEI was done through
comparison against experimental 3JH,H NMR data [38].
The performance of OPLS-AA-SEI in solution phase was evalu-
ated by MD simulation of a-D-gluco- and galactopyranose in TIP3P
[126] water. Rotational preferences around the v dihedral angles
were determined over 10 ns MD simulations and are shown in
Table 1. The new parameter set correctly predicts the stability of
the gg conformer in glucopyranose, whereas the old OPLS-AA
carbohydrate parameter set greatly underestimated the stability
of the gg relative to the gt conformer. For a-D-galactose, the results
between OPLS-AA and OPLS-AA-SEI are very similar, indicating a
modest preference for the gt conformer. Moreover, compared to
OPLS-AA, OPLS-AA-SEI is able to more accurately reproduce the
QM relative energies of gluco-, manno- and galactopyranose [38].
Discussion
A complete parameter set for carbohydrates, directly transferable
to a biomolecular force field, allows for the simulation of complex
hybrid biological systems (such as glycoproteins and glycolipids)
but might not be readily extendible to non-natural carbohydrate-
based ligands. Here, we discuss some of the broader similarities and
differences between each current force field.
Summarized in Table 2 are some of the key characteristics of the
developmental protocols for the four carbohydrate force fields
described in detail in the previous sections. All parameter sets
are built based on training sets of molecules and have been
developed with an eye to maintaining consistency with a larger
biomolecular force field, which commonly includes parameters for
proteins, nucleic acids and lipids. The training sets might include
molecular fragments or monosaccharides and oligosaccharides, or
a combination of both. Each force field also varies in the metrics15 QM geometry optimizations and rotational curves were determined at the
B3LYP/6-31G** and at the RHF/6-31G** levels of theory, respectively, for 1,2-
ethandiol and hexopyranoses.
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TABLE 2
A summary of the parameterization protocol used for the development of four carbohydrate force fields reviewed
CHARMM GLYCAM06 GROMOS-45A4 OPLS-AA-SEI
Valence terms
Equilibrium bond lengths (r)
and angles (u)
Chosen to reproduce crystal
internal and unit-cell geometries
Chosen to reproduce
neutron-diffraction geometries
GROMOS-45A3 OPLS-AA
Force constants kb/ku Fit to QM data Fit to QM data GROMOS-45A3 OPLS-AA
Torsion terms Fit to QM rotational energy
curves
Fit to QM rotational energy
curves
Fit to QM rotational
energy curves
Fit to QM rotational
energy curves
Partial charges Empirically fit for carbohydrate
fragments, and refined to
reproduce: QM solute–water
Eint, and experimental Vm of
carbohydrate solutions
QM RESP fit and ensemble
averaged over multiple
conformations. RESP scaling
to reproduce crystal unit-cell
geometries
QM RESP fit with
averaging over
atom types
OPLS-AA (empirically
fit to reproduce heat
of vaporization and
densities of pure liquids)
vdW terms CHARMM22 AMBER PARM94 GROMOS-45A3 OPLS-AA
1,4 scaling (Elec/vdW) No/no No/no No/no Yes/yes
Unique charge sets
for a- and b-anomers
No Yes No No
Unique charges on each atom No Yes No No
Unique atom types for
a- and b-anomers
Yes No Yes Yes
TABLE 3
Partial atomic chargesa for a- and b-D-glucopyranose in the force
fields reviewed
Atom
name
CHARMM GLYCAM06
(a/b)
GROMOS-
45A4
OPLS-
AA-SEI
C1 0.340 0.509/0.384 0.232 0.365
C2 0.140 0.246/0.310 0.232 0.205
C3 0.140 0.286/0.284 0.232 0.205
C4 0.140 0.254/0.276 0.232 0.205
C5 0.110 0.283/0.225 0.376 0.170
C6 0.050 0.276/0.282 0.232 0.145
O1 0.650 0.639/0.639 0.538 0.700
O2 0.650 0.713/0.718 0.642 0.700
O3 0.650 0.699/0.709 0.642 0.700
O4 0.650 0.710/0.714 0.642 0.700
O5 0.400 0.574/0.471 0.480 0.400
O6 0.650 0.682/0.688 0.642 0.683
HO1 0.420 0.445/0.445 0.410 0.435
HO2 0.420 0.427/0.437 0.410 0.435
HO3 0.420 0.427/0.432 0.410 0.435
HO4 0.420 0.436/0.440 0.410 0.435
HO6 0.420 0.418/0.424 0.410 0.418
H1 0.090 0.000
b –c 0.100
H2 0.090 0.000 – 0.060
H3 0.090 0.000 – 0.060
H4 0.090 0.000 – 0.060
H5 0.090 0.000 – 0.030
H6R, H6S 0.090 0.000 – 0.060
a Charges obtained from the following sources: CHARMM (http://
mackerell.umaryland.edu/CHARMM_ff_params.html); GLYCAM (http://www.glycam.org);
GROMOS-45A4 [136]; OPLS-AA-SEI [123].
b Aliphatic hydrogen atoms constrained to zero charge.
c Aliphatic carbon atoms are represented as united atoms.
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lengths and angles are transferred directly from earlier parameter-
izations in GROMOS-45A4 and OPLS-AA-SEI, whereas both
CHARMM and GLYCAM06 introduce carbohydrate-specific QM-
derived force constants and equilibrium bond and angle proper-
ties. All four force fields present carbohydrate-specific torsion
parameters and point charges, although in GLYCAM06, by virtue
of the fragment-based development, many of the torsion terms are
transferable to other classes of molecule. Obtaining the correct
balance of electrostatic interaction energy and torsion energy is
one of the key aspects in the development of an accurate force field
[127]. As these properties are coupled, however, a robust and
diverse validation protocol needs to be employed. The partial
charges provide a convenient parameter to compare to illustrate
the extent of the differences between each of the force fields.
Variations in the numerical values of the charges for a-D- and b-
D-glucopyranose between each force field (Table 3) reflect the
differences in the manner of their derivation and illustrate the
extent to which transferable partial charges differ from residue-
specific atomic charges. These and other differences make each
parameter set unique and generally incompatible with each other.
Summary and prospectives
The ubiquity of carbohydrates in cell biology and the diversity of
their biological functions make them a fascinating yet complex
research subject. The potential of this field has promoted in the
past five years the development of several high-level parameter sets
specific for carbohydrates, enabling accurate computer simula-
tions. In particular, the compatibility of these parameter sets with
large biomolecular force fields enables us to study complex bio-
molecular systems, such as glycolipids and glycoproteins. Large-
scale computational studies of carbohydrate interactions at the
cell surface are now feasible. Modern sampling techniques
together with accurate force fields could give us an atomistic level
of detail on processes such as cell–cell recognition and cell–matrix
aggregation. Indeed, the molecular basis underlying these events is
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[128].
Various other areas of carbohydrate research would benefit from
the use of computational simulations. Carbohydrate-based drug
design is one of the new frontiers of pharmacology and medicinal
chemistry [129]. The development of synthetic carbohydrates and
carbohydrate derivatives (or glycomimetics) with better pharma-
cokinetic properties is a technical challenge. In fact, the lack of
chemical diversity and complex stereochemistry of carbohydrates
greatly challenges synthetic approaches to all but the simplest
structures. Conversely, several chiral atomic centers make carbo-
hydrates a very useful scaffold for the creation of libraries of high
functional and structural diversity [130]. Given a sufficiently
accurate force field, computational methods could greatly assist
in both carbohydrate-based lead discovery and optimization, thus
avoiding the synthesis and screening of large numbers of com-
pounds. Interesting examples of automated docking in combina-
tion with carbohydrate-specific parameters, and with free-energy
functions designed specifically for carbohydrate–protein interac-
tions, are emerging [131–133].
There have long been two bottlenecks in the application of MD
simulations to practical problems in biomolecular design. The first
is the need for lengthy simulation times to adequately sample
molecular motion, on a timescale of biological relevance.
Advances in code algorithms and computer architecture now
allow simulations of systems containing on the order of 100K
particles to reach the ms timescale in reasonable real time. Thissystem size and timescale enable many biologically relevant sys-
tems, such as protein–carbohydrate complexes, oligosaccharides,
membrane-bound glycolipids and glycoproteins to be simulated
for long enough to provide data that can be employed as a basis to
interpret otherwise sparse experimental data or to predict the
molecular properties a priori. The second long-standing issue is
inaccuracies in force fields, which can often only be identified
through careful critical assessment of data from converged simu-
lations. Although the performance of carbohydrate force fields
rivals or surpasses that of other biomolecular classes, as simulation
times extend, weaknesses in the force fields will continue to be
identified. Thus, longer simulations provide an additional basis for
evaluating force field performance, and it may be anticipated that
features such as charge polarization, lone pair directionality, and
choice of water and ion models are likely to be seen as increasingly
important. The more consistent and generalizable the parameter-
ization scheme, the more readily the sources of any such weak-
nesses may be found and corrected and the easier it will be to
extend them to the study of less-common glycans or to the design
of glycomimetics. Nevertheless, the current performance of car-
bohydrate force fields on problems of real-world significance is
sufficiently accurate that it can be concluded that carbohydrate
modeling has come of age.
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